Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

FC Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 3
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Medical
Summary

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the FC Capital, startups are often financed by GoBeyond, Symbiosis Group, Shumway Capital. The meaningful sponsors for the fund in investment in the same round are Partners Investment, PPF Group, Symbiosis. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2019.

The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Business Development. Among the most popular portfolio startups of the fund, we may highlight Vedanta Biosciences, Cellestia Biotech.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of FC Capital:
Typical Co-investors
FC Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after FC Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amentory Ventures Berlin, Berlin, Germany
Anicut Angel Fund Chennai, India, Tamil Nadu
Aticeo Capital Barcelona, Catalonia, Spain
BDB Ventures New York, New York, United States
Beijing Chunfeng Wanhua Touzi Guanli Youxian Gongsi Beijing, China, Haidian
Cornerstone Holdings Broomfield, Colorado, United States
Cyber Agent Ventures Beijing, Beijing, China
EJF Capital Arlington, United States, Virginia
Gron Ventures California, Newport Beach, United States
Hanwha Investment Bank & Securities Seoul, Seoul-t'ukpyolsi, South Korea
Spacety Changsha, China, Jiangsu
Telindus Camberley, Surrey, United Kingdom
The Ashikaga Bank Japan, Tochigi Prefecture, Utsunomiya
The Kyoto Shinkin Bank Japan, Tokyo
U.S. Trade and Development Agency -
UOB Venture Central Region, Singapore, Singapore
Valor Capital Venture Capital Fund Management Ltd. Budapest, Hungary
Velt Partners Andalucia, Andalusia, Spain
WND Ventures California, Redwood City, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Harvest Integrated Research Organization

Clinical Trials
Medical
$1M18 Mar 2022 Shanghai, Shanghai, China

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M17 Dec 2019 Lausanne, Vaud, Switzerland

Vedanta Biosciences

Biotechnology
Business Development
Drug Discovery
Medical
$16M23 Sep 2019 Cambridge, Massachusetts, United States

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M19 Dec 2018 Lausanne, Vaud, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent FC Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 15M
Peak activity year 2019
Lead investments 1
Follow on index 0.25
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Harvest Integrated Research Organization

Clinical Trials
Medical
$1M18 Mar 2022 Shanghai, Shanghai, China

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M17 Dec 2019 Lausanne, Vaud, Switzerland

Vedanta Biosciences

Biotechnology
Business Development
Drug Discovery
Medical
$16M23 Sep 2019 Cambridge, Massachusetts, United States

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M19 Dec 2018 Lausanne, Vaud, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: